Kestra Advisory Services, LLC Infla Rx N.V. Transaction History

Kestra Advisory Services, LLC

  • $17.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
BUY
$2.11 - $3.25 $9,917 - $15,275
4,700 Added 42.73%
15,700 $48,000
Q3 2022

Nov 01, 2022
BUY
$1.32 - $3.14 $1,320 - $3,140
1,000 Added 10.0%
11,000 $29 Million
Q2 2022

Aug 12, 2022
BUY
$0.78 - $1.9 $7,800 - $19,000
10,000 New
10,000 $15,000

Others Institutions Holding IFRX

# of Institutions
29
Shares Held
12.9M
Call Options Held
19.3K
Put Options Held
0
View Full List

About InflaRx N.V.

IFRX Quotes by TradingView
  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $77.4M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email